CoreWeave’s (CRWV) Acquisition Bid for Core Scientific Faces Major Pushback

CoreWeave's (CRWV) planned acquisition of bitcoin mining firm Core Scientific (CORZ) is facing significant shareholder opposition, with Core Scientific's largest active shareholder, Two Seas Capital, urging investors to reject the deal ahead of the October 30 vote. Two Seas contends the acquisition, valuing CORZ at $17.50 per share, severely undervalues the company given the booming AI infrastructure market and the substantial outperformance of industry peers since the deal's July 2025 announcement, which has seen CRWV's stock decline and drag down the implied value. This shareholder revolt underscores growing concerns over valuation discrepancies in the rapidly expanding AI infrastructure sector.

Analysis

CoreWeave's (CRWV) proposed acquisition of Core Scientific (CORZ) faces significant opposition from CORZ's largest active shareholder, Two Seas Capital, ahead of the October 30 shareholder vote. Two Seas argues the $17.50 per share valuation, based on an exchange with CRWV stock, severely undervalues CORZ, especially given the booming demand for AI infrastructure. This dissent highlights a material risk to the deal's completion and introduces uncertainty.

Since the July 2025 announcement, CORZ's stock has only risen 9%, while comparable AI infrastructure peers like Applied Digital (APLD), Cipher Mining (CIFR), and TeraWulf (WULF) have seen their stock prices triple or quadruple. Concurrently, CRWV's stock has declined 15%, further eroding the implied deal value. Two Seas estimates CORZ's fair value could be around $45 per share if it had matched its weakest peer's performance, contrasting sharply with the current offer.

Despite the acquisition challenges, CoreWeave is actively strengthening its AI cloud infrastructure business, evidenced by the appointment of former Amazon executive Jon Jones as its first Chief Revenue Officer. This strategic hire aims to drive growth and leverage partnerships with key players like OpenAI. Wall Street analysts maintain a "Moderate Buy" consensus on CRWV, with an average price target of $152.60, implying a 17.51% upside, suggesting underlying confidence in its core business despite the M&A headwinds.

Key Decisions for Investors

• Investors in Core Scientific (CORZ) should carefully evaluate the Two Seas Capital presentation and the potential for a higher offer or standalone value, considering the October 30 shareholder vote.
• Monitor CoreWeave's (CRWV) stock performance and the broader AI infrastructure market, as the current deal's implied value is sensitive to CRWV's share price fluctuations.
• Consider the implications of a failed acquisition for both CRWV's strategic growth plans and CORZ's future as an independent entity in a high-demand sector.